Get access

Redefining Rowell’s syndrome

Authors

  • N.C. Zeitouni,

    1. Centre Hospitalier Universitaire de Québec, Service de Dermatologie, Pavillon-Hôtel-Dieu de Québec, 11 Côte du Palais,
      Quebec PQ G1R 2J6, Canada
    Search for more papers by this author
  • D. Funaro,

    1. Centre Hospitalier Universitaire de Québec, Service de Dermatologie, Pavillon-Hôtel-Dieu de Québec, 11 Côte du Palais,
      Quebec PQ G1R 2J6, Canada
    Search for more papers by this author
  • R.A. Cloutier,

    1. Centre Hospitalier Universitaire de Québec, Service de Dermatologie, Pavillon-Hôtel-Dieu de Québec, 11 Côte du Palais,
      Quebec PQ G1R 2J6, Canada
    Search for more papers by this author
  • E. Gagné,

    1. Centre Hospitalier Universitaire de Québec, Service de Dermatologie, Pavillon-Hôtel-Dieu de Québec, 11 Côte du Palais,
      Quebec PQ G1R 2J6, Canada
    Search for more papers by this author
  • J. Claveau

    1. Centre Hospitalier Universitaire de Québec, Service de Dermatologie, Pavillon-Hôtel-Dieu de Québec, 11 Côte du Palais,
      Quebec PQ G1R 2J6, Canada
    Search for more papers by this author

Nathalie C.Zeitouni, Department of Dermatology, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263-0001, U.S.A. E-mail: nzeitouni@SC3103.med.buffalo.edu

Abstract

Rowell’s syndrome is believed to be a distinct and rare clinical entity originally described as lupus erythematosus associated with erythema multiforme-like lesions with immunological findings of speckled antinuclear antibodies, anti-La antibodies and a positive test for rheumatoid factor. We report two additional patients with Rowell’s syndrome and review all the diagnostic criteria found in the literature. In view of the inconsistent findings of some of the diagnostic features, we propose that major and minor criteria be used to diagnose Rowell’s syndrome.

Ancillary